生物谷8 天
《癌细胞》：更新换代，效果不赖！临床前研究显示，新一代CDK4选择 ...
Atirmociclib作为一种CDK4选择性抑制剂，与现有的CDK4/6抑制剂哌柏西利相比，其在结构上对CDK4的亲和力更高，选择性更强。 细胞 ...
Cure Today13 天
Understanding the Best Practices Associated With CDK4/6 Therapy in Breast Cancer
Dr. Sara M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer. At the 42nd Annual Miami Breast Cancer Conference, Dr. Sara M. Tolaney sat down for ...